Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2009-06-03
2011-10-11
Saoud, Christine J (Department: 1647)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S399000
Reexamination Certificate
active
08034770
ABSTRACT:
The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4301144 (1981-11-01), Iwashita et al.
patent: 4376110 (1983-03-01), David et al.
patent: 4496689 (1985-01-01), Mitra
patent: 4640835 (1987-02-01), Shimizu et al.
patent: 4670417 (1987-06-01), Iwasaki et al.
patent: 4791192 (1988-12-01), Nakagawa et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4970154 (1990-11-01), Chang
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5106627 (1992-04-01), Aebischer et al.
patent: 5217889 (1993-06-01), Roninson et al.
patent: 5229501 (1993-07-01), Keifer et al.
patent: 5234784 (1993-08-01), Aslam et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5272071 (1993-12-01), Chappel
patent: 5288855 (1994-02-01), Bergonzoni et al.
patent: 5364791 (1994-11-01), Vegeto et al.
patent: 5489743 (1996-02-01), Robinson et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5557032 (1996-09-01), Mak
patent: 5585089 (1996-12-01), Queen et al.
patent: 5589362 (1996-12-01), Bujard et al.
patent: 5593875 (1997-01-01), Wurm et al.
patent: 5635399 (1997-06-01), Kriegler et al.
patent: 5650298 (1997-07-01), Bujard et al.
patent: 5654168 (1997-08-01), Bujard et al.
patent: 5670323 (1997-09-01), Nova et al.
patent: 5672510 (1997-09-01), Eglitis et al.
patent: 5676954 (1997-10-01), Brigham
patent: 5679559 (1997-10-01), Kim et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5707632 (1998-01-01), Williams et al.
patent: 5811234 (1998-09-01), Roninson et al.
patent: 6133426 (2000-10-01), Gonzalez et al.
patent: 6150098 (2000-11-01), Zhang
patent: 6214795 (2001-04-01), Benjamin et al.
patent: 6255454 (2001-07-01), Kiefer et al.
patent: 6350593 (2002-02-01), Williams et al.
patent: 6355440 (2002-03-01), Williams et al.
patent: 6384191 (2002-05-01), Williams et al.
patent: 6548634 (2003-04-01), Ballinger et al.
patent: 6579850 (2003-06-01), Nabeshima et al.
patent: 6639063 (2003-10-01), Edwards
patent: 6716626 (2004-04-01), Itoh
patent: 6844168 (2005-01-01), Keifer et al.
patent: 7259248 (2007-08-01), Itoh
patent: 7288406 (2007-10-01), Bogin et al.
patent: 7408047 (2008-08-01), Thomason
patent: 7491697 (2009-02-01), Beals
patent: 7531304 (2009-05-01), Bange et al.
patent: 7563769 (2009-07-01), Bogin et al.
patent: 7645857 (2010-01-01), Zhou et al.
patent: 7667005 (2010-02-01), Nabeshima et al.
patent: 7678890 (2010-03-01), Bosch et al.
patent: 7695938 (2010-04-01), Thomason et al.
patent: 7696172 (2010-04-01), Thomason et al.
patent: 7700558 (2010-04-01), Thomason et al.
patent: 7704952 (2010-04-01), Thomason et al.
patent: 7727742 (2010-06-01), Thomason et al.
patent: 7879323 (2011-02-01), Thomason et al.
patent: 7887799 (2011-02-01), Thomason et al.
patent: 2001/0012628 (2001-08-01), Agarwal et al.
patent: 2002/0081663 (2002-06-01), Conklin
patent: 2002/0164713 (2002-11-01), Itoh
patent: 2003/0220246 (2003-11-01), Conklin
patent: 2004/0018499 (2004-01-01), Lal
patent: 2004/0185494 (2004-09-01), Itoh
patent: 2004/0259780 (2004-12-01), Glasebrook
patent: 2005/0037457 (2005-02-01), Itoh
patent: 2005/0176631 (2005-08-01), Heuer
patent: 2005/0187150 (2005-08-01), Mohammadi et al.
patent: 2006/0223114 (2006-10-01), Stemmer
patent: 2007/0036806 (2007-02-01), Glaesner
patent: 2007/0128619 (2007-06-01), Itoh
patent: 2007/0142278 (2007-06-01), Beals
patent: 2007/0237768 (2007-10-01), Glaesner
patent: 2007/0238657 (2007-10-01), Itoh
patent: 2007/0265200 (2007-11-01), Glaesner
patent: 2007/0293430 (2007-12-01), Frye
patent: 2007/0299007 (2007-12-01), Frye
patent: 2008/0071065 (2008-03-01), Thomason
patent: 2008/0071066 (2008-03-01), Thomason
patent: 2008/0103096 (2008-05-01), Frye
patent: 2008/0242607 (2008-10-01), DeFrees
patent: 2008/0248959 (2008-10-01), DeFrees
patent: 2008/0253992 (2008-10-01), DeFrees et al.
patent: 2008/0255040 (2008-10-01), DeFrees
patent: 2008/0255045 (2008-10-01), Cujec
patent: 2008/0261236 (2008-10-01), Kuro-o
patent: 2008/0261875 (2008-10-01), Etgen
patent: 2008/0274958 (2008-11-01), DeFrees
patent: 2009/0074776 (2009-03-01), Itoh
patent: 2009/0118190 (2009-05-01), Beals et al.
patent: 2009/0123462 (2009-05-01), Bange et al.
patent: 2009/0192087 (2009-07-01), Glass et al.
patent: 2009/0305986 (2009-12-01), Belouski et al.
patent: 2010/0158911 (2010-06-01), Williams et al.
patent: 2010/0158914 (2010-06-01), Desnoyers
patent: 2010/0184665 (2010-07-01), Suzuki et al.
patent: 2010/0226921 (2010-09-01), Thomason et al.
patent: 2010/0233169 (2010-09-01), Thomason et al.
patent: 2010/0285131 (2010-11-01), Belouski et al.
patent: 2010/0310566 (2010-12-01), Thomason et al.
patent: 2011/0003302 (2011-01-01), Thomason et al.
patent: 0036676 (1981-09-01), None
patent: 0058481 (1982-08-01), None
patent: 0088046 (1983-09-01), None
patent: 0133988 (1985-03-01), None
patent: 0143949 (1985-06-01), None
patent: 0154316 (1985-09-01), None
patent: 0401384 (1990-12-01), None
patent: 0545343 (1993-06-01), None
patent: 0315456 (1994-06-01), None
patent: 0546073 (1997-09-01), None
patent: 2060270 (2009-05-01), None
patent: 2163626 (2010-03-01), None
patent: 90/04036 (1990-04-01), None
patent: 91/09955 (1991-07-01), None
patent: 91/10425 (1991-07-01), None
patent: 91/10470 (1991-07-01), None
patent: 91/10741 (1991-07-01), None
patent: 93/15722 (1993-08-01), None
patent: 94/02602 (1994-02-01), None
patent: 94/20069 (1994-09-01), None
patent: 94/28122 (1994-12-01), None
patent: 95/05452 (1995-02-01), None
patent: 95/34670 (1995-12-01), None
patent: 96/11953 (1996-04-01), None
patent: 96/32478 (1996-10-01), None
patent: 96/33735 (1996-10-01), None
patent: 96/37609 (1996-11-01), None
patent: 96/40958 (1996-12-01), None
patent: 96/41865 (1996-12-01), None
patent: 97/31899 (1997-09-01), None
patent: 97/34631 (1997-09-01), None
patent: 99/10494 (1999-03-01), None
patent: 00/18921 (2000-04-01), None
patent: 00/24782 (2000-05-01), None
patent: 00/54813 (2000-09-01), None
patent: 01/18172 (2001-03-01), None
patent: 01/18209 (2001-03-01), None
patent: 01/32678 (2001-05-01), None
patent: 01/36640 (2001-05-01), None
patent: 01/38357 (2001-05-01), None
patent: 01/49849 (2001-07-01), None
patent: 01/72957 (2001-10-01), None
patent: 03/011213 (2003-02-01), None
patent: 03/059270 (2003-07-01), None
patent: 2004/044011 (2004-05-01), None
patent: 2004/110472 (2004-12-01), None
patent: 2005/037235 (2005-04-01), None
patent: 2005/061712 (2005-07-01), None
patent: 2005/072769 (2005-08-01), None
patent: 2005/091944 (2005-10-01), None
patent: 2005/113606 (2005-12-01), None
patent: 2006/028595 (2006-03-01), None
patent: 2006/028714 (2006-03-01), None
patent: 2006/050247 (2006-05-01), None
patent: 2006/065582 (2006-06-01), None
patent: 2006/078463 (2006-07-01), None
patent: 2007/055789 (2007-05-01), None
patent: 2007/100695 (2007-09-01), None
patent: 2008/011633 (2008-01-01), None
patent: 2008/121563 (2008-10-01), None
patent: 2008/151258 (2008-12-01), None
patent: 2008/153705 (2008-12-01), None
patent: 2009/020802 (2009-02-01), None
patent: 2009149171 (2009-12-01), None
patent: 2010006214 (2010-01-01), None
patent: 2010129503 (2010-11-01), None
Nishimura et al. (2000), “Identification of a novel FGF, FGF-21, preferentially expressed in the liver(I).” Biochim Biophys Acta 21: 203-6.
Parthiban et al., 2006, “MSH2 is essential for the preservation of genome integrity and prevents homeologous recombination in the mossPhyscomitrella patens” Nucleic Acids of Res. 34: 232-42.
Plotnikov et al. (1999), “Structural Basis for FGF Receptor Dimerization and Activation” Cell 98: 641-650.
Riechmann et al., 1998, “Reshaping human antibodies for therapy” Nature 332: 323-27.
Sidman et al., 1983, “Controlled release of macromolecules and phar
Belouski Edward John
Ellison Murielle Marie
Hamburger Agnes Eva
Hecht Randy Ira
Li Yue-Sheng
Amgen Inc.
Lamerdin John A.
Saoud Christine J
LandOfFree
FGF21 polypeptides comprising two or more mutations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with FGF21 polypeptides comprising two or more mutations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and FGF21 polypeptides comprising two or more mutations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262991